Hansa Biopharma announces first commercial kidney transplant patient treated with Idefirix in Australia

Summary

Hansa Biopharma announced the first commercial kidney transplant patient in Australia treated with Idefirix (imlifidase) following a living donor transplant. This represents a routine commercial milestone for the company's approved therapeutic.